Lupin Quarterly Results for Trading Insights

LUPIN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,485 Cr
QSept 2025
Quarterly Results

Lupin Quarterly Results Key Highlights

  • Revenue of ₹6,921 Cr in Sept 2025 (+23.2% vs Mar 2025, +25.0% vs Sept 2024)
  • Net Profit of ₹1,485 Cr in Sept 2025 (+89.9% vs Mar 2025, +72.7% vs Sept 2024)
  • EBITDA of ₹2,215 Cr in Sept 2025 (+74.0% vs Mar 2025)
  • Operating Margin of 31.0% in Sept 2025 (+9.0pp vs Mar 2025)
  • Earnings Per Share of ₹32.36 in Sept 2025 (+91.1% vs Mar 2025)

Lupin Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 6,921 5,619 6,243 7,215 5,539 23.2% 25.0%
Net Profit (₹ Cr) 1,485 782 1,222 1,181 860 - -
EBITDA (₹ Cr) 2,215 1,273 1,702 1,883 1,207 - -
EPS (₹) 32.36 16.93 26.70 25.74 18.70 - -
Operating Margin (%) 31.0% 22.0% 26.0% 25.0% 21.0% - -

Lupin Share Price Trend Around Quarterly Results

Visualize Lupin's 1-year price movement across quarterly results — ideal for logging trades in Lupin share price chart using Tickjournal. All values in ₹.

Related Pages for Lupin

Additional stock information and data for LUPIN

LUPIN earnings multiple
LUPIN shareholder distribution
LUPIN value investing
Lupin financial data
LUPIN fair value
LUPIN price book multiple
LUPIN enterprise value

Profitability Ratios

Profit Margin 21.5%
EBITDA Margin 32.0%
Operating Margin 31.0%
ROE (Annual) 34.3%

Balance Sheet Highlights

Total Assets ₹29,205 Cr
Total Equity ₹17,294 Cr
Current Assets ₹16,799 Cr
Current Liabilities ₹2,949 Cr

Cash Flow Analysis

Operating Cash Flow ₹3,000 Cr
Investing Cash Flow ₹-4,172 Cr
Financing Cash Flow ₹1,732 Cr
Net Cash Flow ₹560 Cr

Current Market Data

Current Price ₹2219.40
Exchange NSE
Last Updated Feb 20, 2026

Revenue Trend (₹ Cr)

Dec 2025 7,215
Jun 2025 6,243
Mar 2025 5,619
Sept 2025 6,921

Net Profit Trend (₹ Cr)

Dec 2025 1,181
Jun 2025 1,222
Mar 2025 782
Sept 2025 1,485

Operating Margin Trend (%)

Dec 2025 25.0%
Jun 2025 26.0%
Mar 2025 22.0%
Sept 2025 31.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Lupin quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹413,741.32 Cr 1724.4 14,875 3,125 +10.8% - 21.0% 132.6
Divis Laboratories
Sept 2025 		₹167,006.28 Cr 6291.0 2,860 689 +7.1% - 24.1% 242.2
Torrent Pharmaceuti…
Sept 2025 		₹138,018.05 Cr 4241.7 3,219 591 +11.3% - 18.4% 241.8
Cipla
Sept 2025 		₹107,554.81 Cr 1341.1 7,716 1,353 +12.0% - 17.5% 80.2
Dr Reddys Laborator…
Sept 2025 		₹106,866.07 Cr 1280.4 9,135 1,337 +1.1% - 14.6% 79.1
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores